As of Feb. 4, 2026, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, acco ...

Core Insights - Silicon Motion Technology Corporation (SIMO) reported mixed fourth-quarter 2025 results, with revenues exceeding estimates while adjusted earnings fell short [1] Financial Performance - Net income on a GAAP basis improved to $47.7 million or $1.41 per American depositary share (ADS) from $21.6 million or 64 cents per ADS in the prior-year quarter, primarily due to higher net sales [3] - Non-GAAP net income was $42.7 million or $1.26 per ADS compared to $29.4 million or 87 cents per ADS in the year-ago quarter, missing the Zacks Consensus Estimate of $1.29 per ADS [3] - For 2025, GAAP net income was $122.6 million or $3.64 per ADS compared to $89.2 million or $2.65 per ADS in 2024 [4] - Non-GAAP net income for 2025 was $119.8 million or $3.55 per ADS compared to $114.5 million or $3.39 per ADS in 2024 [4] Revenue Growth - Quarterly revenues increased to $278.5 million from $191.2 million in the year-ago quarter, beating the Zacks Consensus Estimate of $261.2 million [5] - For 2025, revenues rose to $885.6 million from $803.6 million in 2024 [5] - Sales of SSD controllers increased by 35-40% year over year, while eMMC + UFS sales grew by 50-55%, and revenues in SSD solutions surged by 110-115% year over year [6] Profitability Metrics - Non-GAAP gross profit reached $137 million compared to $87.9 million in the year-ago quarter, with respective margins of 49.2% and 46% [7] - For 2025, non-GAAP gross profit increased to $427.9 million from $369.3 million in 2024, with margins of 48.3% and 46% [7] - Non-GAAP operating expenses rose to $83.2 million from $58.3 million in the prior year, but non-GAAP operating income increased to $53.8 million from $29.6 million, with margins of 19.3% and 15.5% respectively [8] Cash Flow and Liquidity - As of December 31, 2025, cash and cash equivalents were $201.8 million compared to $276.1 million a year ago [9] - The company generated $1.6 million in cash from operations during the reported quarter, down from $6.2 million in the prior-year quarter [10] - For 2025, cash generated from operating activities was $61.4 million compared to $77.1 million in 2024 [10] Future Guidance - For the first quarter of 2026, management estimates non-GAAP revenues in the range of $292-$306 million, with a gross margin expected to be between 46-47% [11]

Core Insights - Newmont Corporation (NEM) is enhancing shareholder value through significant dividends and share repurchases, distributing over $5.7 billion in the past two years [1][7] Financial Performance - Newmont generated a record free cash flow of $1.6 billion in Q3, with net cash from operating activities increasing by 40% year-over-year to $2.3 billion [2][7] - The company reduced its debt by approximately $2 billion in Q3, achieving a near-zero net debt position by the end of the quarter [3][7] Capital Allocation - Newmont has doubled its share repurchase authorization to $6 billion, executing $3.3 billion of this buyback as of October 23, 2025 [2] - The company is following a disciplined capital allocation policy, using its cash generation to return capital to shareholders, fund growth projects, and pay down debt [3] Market Position - Newmont's shares have increased by 79.2% over the past six months, outperforming the Zacks Mining – Gold industry, which rose by 64.8% [6] - The company is currently trading at a forward 12-month earnings multiple of 15.23, which is a 15% premium to the industry average of 13.24 [9] Earnings Outlook - The Zacks Consensus Estimate for NEM's earnings implies a year-over-year increase of 81.9% for 2025 and 21.1% for 2026, with EPS estimates trending higher over the past 60 days [10]

As of Feb. 4, 2026, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, acco ...

Core Viewpoint - VolitionRx Limited is sponsoring a symposium at the European Hidradenitis Suppurativa Foundation Conference to present findings on the Nu.Q NETs assay, which aids in the management of Hidradenitis Suppurativa (HS) through a precision medicine approach [1][2][3]. Company Overview - VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics and improving outcomes for patients through earlier detection and monitoring of diseases [11][12]. - The company is developing cost-effective blood tests for various diseases, including cancers and conditions associated with NETosis, aiming to enhance patient quality of life [12]. Industry Context - Hidradenitis Suppurativa (HS) is a chronic condition affecting approximately 1% of the global population, characterized by painful skin abscesses and scarring [3][9]. - The condition is difficult to manage, and the introduction of biological treatments has shown varied responses among patients, highlighting the need for a precision medicine approach [4][9]. Product and Market Potential - The Nu.Q NETs assay is CE-Marked for clinical use in 27 EU member states and is positioned as a simple, low-cost test to detect diseases associated with NETosis, with a total addressable market estimated at $3.8 billion [6][8]. - The assay aims to classify HS patients and guide treatment decisions, potentially improving patient management and outcomes [4][6].

8:30 a.m. Eastern Time Interested parties can listen to the call via live webcast. Please access 5-10 minutes before the call: PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. ("Cinemark†) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that it will report its fourth quarter and full year 2025 operating results pre-market and host a webcast and to discuss the results on: Wednesday, February 18, 2026 https://event.choruscall.com/media ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers Report. The findings show that value-based care helps Medicare Advantage patients receive more personalized, preventive care while improving their overall health experience. Every path in value-based care leads to one goal: helping people achieve their best health." -Alex Ding, M.D., Deputy Chief Medical Of ...

Core Viewpoint - Defiance ETFs has launched the Defiance Daily Target 2X Long ZETA ETF (ZETX), aimed at active traders seeking amplified exposure to Zeta Global Holdings Corp., a company specializing in AI-powered marketing solutions [1][2]. Investment Objective - The Fund aims to achieve daily investment results of 200% of the daily percentage change in the share price of Zeta Global Holdings Corp. – Class A [3]. Underlying Stock - Zeta Global Holdings Corp. is a software company that offers an AI-powered marketing platform, helping enterprises analyze consumer data and automate personalized marketing across various digital channels [4]. Fund Characteristics - The ETF is not a direct investment in Zeta Global Holdings Corp. and is designed for knowledgeable investors who understand the risks associated with leveraged investments [5][6]. - The Fund's performance is strictly for short-term use, and it is subject to risks associated with leverage, including the potential for significant losses [7][10]. Market Context - Zeta Global Holdings Corp. operates within the software industry, focusing on AI and digital marketing, which are critical areas for growth in the current market environment [4].

Core Viewpoint - The article emphasizes a personal investment strategy focused on growth and dividend income, aiming for an easy retirement through a portfolio designed for compounding dividend income and growth [1]. Group 1: Investment Strategy - The strategy involves creating a portfolio that generates monthly dividend income, which is enhanced through dividend reinvestment and annual increases [1]. - The author expresses a beneficial long position in the shares of ENB, indicating a personal investment in the company [1]. Group 2: Personal Opinion and Disclosure - The article is presented as a personal opinion and not as professional investment advice, highlighting that it is meant for research and educational purposes [2]. - It clarifies that past performance does not guarantee future results, and the views expressed may not reflect those of Seeking Alpha as a whole [3].

Graham Corporation (NYSE:GHM) is included among the 12 Best HVAC Stocks to Buy Now. Northland Sees Graham Corporation (GHM) Near Full Value as Order Growth Slows Photo by Vitaly Taranov on Unsplash On January 27, Northland downgraded Graham Corporation (NYSE:GHM) to Market Perform from Outperform and raised its price target to $80 from $71. The firm remains constructive on Graham’s acquisition of FlackTek, which produces proprietary material processing solutions. Still, the analyst said the stock now ap ...